glp-1 obesity drug news today october 2025 WHO Decision Recognizing as a Disease Treatable with Drugs Is “Big Deal,” says BU Endocrinologist | BU pharma news today obesity drugs

Mc homocysteine cao nh hng tiu cc n chc nng no b bi n gy ra tnh trng thiu mu ln no cng nh cc dy thn kinh

Biomedicines 10 , 3067 (2022)

For a subcutaneous injection, which goes into the fatty tissue just beneath the skin, a 45-degree angle is best

As your skin adjusts, you can gradually increase to twice daily use if needed

These factors can lead to low B12 levels, causing symptoms such as fatigue, memory problems, and neuropathy (tingling in the hands and feet)

Your path to significant weight loss with cagrilintide requires commitment to proper titration, managing side effects proactively, maintaining adequate protein and hydration, supporting with diet and exercise, and understanding this is a long-term approach requiring 12-18+ months for maximum results and ongoing maintenance to prevent regain